Although upregulation of hypoxia response transcription factor HIF1-α is frequently observed in ovarian cancer, an established relationship between hypoxia and resistance to taxane chemotherapy has yet to be elucidated [49,288]. Here, HIF1A is linked to ovarian cancer.